Data from EMA (European Medicines Agency) - Curated by Toby Galbraith - Last updated 06 September 2017

Indication(s)

Ledaga is indicated for the topical treatment of mycosis fungoides-type cutaneous T-cell lymphoma (MF-type CTCL) in adult patients.

Full Prescribing information

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Acute and Advanced Heart Failure

What are the most effective treatments for acute heart failure? Can you define advanced heart failure? Discover here...

Visit Acute and Advanced Heart Failure

IL-17A in Psoriasis

Experts discuss new targeted therapies for psoriasis at the European Association of Dermatology and Venereology (EADV) Congress.

Visit IL-17A in Psoriasis

Related Content

More information

Category Value
Agency product number EMEA/H/C/002826
Orphan designation Yes
Date First Approved 03-03-2017
Type Medicinal product subject to medical prescription
Marketing authorisation holder Actelion Registration Ltd.